• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病:典型的神经精神障碍。

Parkinson's disease: the quintessential neuropsychiatric disorder.

机构信息

Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

出版信息

Mov Disord. 2011 May;26(6):1022-31. doi: 10.1002/mds.23664.

DOI:10.1002/mds.23664
PMID:21626547
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3513835/
Abstract

Although diagnosed by characteristic motor features, Parkinson's disease may be preceded, and is frequently accompanied by, a wide range of cognitive and neuropsychiatric features. In addition to the most commonly studied disorders of dementia, depression, and psychosis, other relatively common and clinically significant psychiatric complications include impulse control disorders, anxiety symptoms, disorders of sleep and wakefulness, and apathy. These problems may be underrecognized and are frequently undertreated. The emergent focus on nonmotor aspects of Parkinson's disease over the past quarter of a century is highlighted by a nonlinear increase in the number of articles published devoted to this topic. Although the development of newer antidepressants, atypical antipsychotics, and cholinesterase inhibitors in recent years has had a positive benefit on the management of these troublesome and distressing symptoms, responses are frequently suboptimal, and this remains an area of major unmet therapeutic need.

摘要

尽管帕金森病可以通过典型的运动特征来诊断,但它可能会先于一系列广泛的认知和神经精神特征出现,并且经常伴随着这些特征。除了最常研究的痴呆、抑郁和精神病障碍外,其他相对常见且具有临床意义的精神并发症包括冲动控制障碍、焦虑症状、睡眠和觉醒障碍以及冷漠。这些问题可能未被识别,并且经常治疗不足。过去四分之一个世纪对帕金森病非运动方面的关注日益增加,这突出体现在专门针对这一主题的文章数量呈非线性增长。尽管近年来新型抗抑郁药、非典型抗精神病药和胆碱酯酶抑制剂的发展对这些麻烦和令人痛苦的症状的管理产生了积极的影响,但反应往往并不理想,这仍然是一个主要的未满足的治疗需求领域。

相似文献

1
Parkinson's disease: the quintessential neuropsychiatric disorder.帕金森病:典型的神经精神障碍。
Mov Disord. 2011 May;26(6):1022-31. doi: 10.1002/mds.23664.
2
Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options.帕金森病中的认知缺陷与精神病:病理生理学及治疗选择综述
CNS Drugs. 2006;20(6):477-505. doi: 10.2165/00023210-200620060-00004.
3
Neuropsychiatric Issues in Parkinson's Disease.帕金森病的神经精神问题。
Curr Neurol Neurosci Rep. 2016 May;16(5):49. doi: 10.1007/s11910-016-0647-4.
4
Milestones in Parkinson's disease therapeutics.帕金森病治疗的里程碑。
Mov Disord. 2011 May;26(6):1072-82. doi: 10.1002/mds.23714.
5
Personality, dopamine, and Parkinson's disease: Insights from subthalamic stimulation.人格、多巴胺与帕金森病:来自丘脑底核刺激的见解
Mov Disord. 2017 Aug;32(8):1191-1200. doi: 10.1002/mds.27065. Epub 2017 Jun 23.
6
Psychiatric symptoms in Parkinson's disease.帕金森病中的精神症状
Eur Arch Psychiatry Clin Neurosci. 2008 Nov;258 Suppl 5:55-9. doi: 10.1007/s00406-008-5012-4.
7
[Nonmotor signs of Parkinson's disease].[帕金森病的非运动症状]
Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(5):81-5.
8
[Neuropsychiatric manifestations in Parkinson's disease].[帕金森病的神经精神表现]
Psychiatriki. 2015 Apr-Jun;26(2):116-30.
9
Psychiatric aspects of Parkinson's disease--an update.帕金森病的精神方面——最新进展
J Neurol. 2004 Jul;251(7):795-804. doi: 10.1007/s00415-004-0483-3.
10
Neuropsychiatric aspects of Parkinson's disease.帕金森病的神经精神方面
Curr Psychiatry Rep. 1999 Oct;1(1):61-8. doi: 10.1007/s11920-999-0011-3.

引用本文的文献

1
Parkinson's Disease Caregiving, Level of Care Burden, Caregiving-Related Strain, and Caregiver Health.帕金森病护理、护理负担水平、与护理相关的压力及护理人员健康状况。
Healthcare (Basel). 2025 Jun 26;13(13):1520. doi: 10.3390/healthcare13131520.
2
Mapping the landscape of brain stimulation research: A global scientometric review on cognitive impairment.绘制脑刺激研究全景:关于认知障碍的全球科学计量学综述
Ibrain. 2025 Mar 22;11(2):185-204. doi: 10.1002/ibra.12194. eCollection 2025 Summer.
3
Proteome-Wide Association Study for Finding Druggable Targets in Progression and Onset of Parkinson's Disease.全蛋白质组关联研究以寻找帕金森病进展和发病过程中的可成药靶点。
CNS Neurosci Ther. 2025 Feb;31(2):e70294. doi: 10.1111/cns.70294.
4
Parkinson's Disease and Caregiving Roles, Demands, and Support Needs and Experiences: A Scoping Review.帕金森病与照料角色、需求、支持需求及经历:一项范围综述
Healthcare (Basel). 2025 Jan 4;13(1):79. doi: 10.3390/healthcare13010079.
5
Electrode Location and Domain-Specific Cognitive Change Following Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease.帕金森病丘脑底核深部脑刺激术后电极位置与特定领域认知变化
Neurosurgery. 2024 Nov 8;97(1):148-156. doi: 10.1227/neu.0000000000003271.
6
A Cognitive-Behavioral Model of Apathy in Parkinson's Disease.帕金森病冷漠的认知行为模型。
Parkinsons Dis. 2024 Aug 31;2024:2820257. doi: 10.1155/2024/2820257. eCollection 2024.
7
The potential of arts therapies in Parkinson's disease rehabilitation: A comprehensive review.艺术疗法在帕金森病康复中的潜力:一项综述
Heliyon. 2024 Aug 3;10(16):e35765. doi: 10.1016/j.heliyon.2024.e35765. eCollection 2024 Aug 30.
8
Continuous and Unconstrained Tremor Monitoring in Parkinson's Disease Using Supervised Machine Learning and Wearable Sensors.使用监督式机器学习和可穿戴传感器对帕金森病进行连续无约束震颤监测
Parkinsons Dis. 2024 May 20;2024:5787563. doi: 10.1155/2024/5787563. eCollection 2024.
9
Alterations in cortical volume and complexity in Parkinson's disease with depression.帕金森病伴发抑郁患者皮质体积和复杂度的改变。
CNS Neurosci Ther. 2024 Feb;30(2):e14582. doi: 10.1111/cns.14582.
10
Investigating the association between a history of depression and biomarkers of Alzheimer's disease, cerebrovascular disease, and neurodegeneration in patients with dementia.探讨痴呆患者中抑郁症病史与阿尔茨海默病、脑血管病和神经退行性变生物标志物之间的关联。
Geroscience. 2024 Feb;46(1):783-793. doi: 10.1007/s11357-023-01030-x. Epub 2023 Dec 14.

本文引用的文献

1
The most cited works in Parkinson's disease.帕金森病领域最具引用价值的文献
Mov Disord. 2011 Feb 15;26(3):380-90. doi: 10.1002/mds.23445. Epub 2010 Nov 10.
2
Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study.横断面研究显示:金刚烷胺的使用与帕金森病患者的冲动控制障碍有关。
Ann Neurol. 2010 Dec;68(6):963-8. doi: 10.1002/ana.22164.
3
Quality improvement in neurology: AAN Parkinson disease quality measures: report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology.神经病学质量改进:美国神经病学学会帕金森病质量测量标准:美国神经病学学会质量测量和报告小组委员会的报告。
Neurology. 2010 Nov 30;75(22):2021-7. doi: 10.1212/WNL.0b013e3181ff96dd.
4
Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.帕金森病患者的轻度认知障碍:一项多中心汇总分析。
Neurology. 2010 Sep 21;75(12):1062-9. doi: 10.1212/WNL.0b013e3181f39d0e.
5
The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: a randomized, double-blind, placebo-controlled study.左前额重复经颅磁刺激对帕金森病抑郁的影响:一项随机、双盲、安慰剂对照研究。
Mov Disord. 2010 Oct 30;25(14):2311-7. doi: 10.1002/mds.23270.
6
Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial.美金刚治疗帕金森病痴呆或路易体痴呆患者的随机、双盲、安慰剂对照试验。
Lancet Neurol. 2010 Oct;9(10):969-77. doi: 10.1016/S1474-4422(10)70194-0. Epub 2010 Aug 20.
7
CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease.脑脊液淀粉样蛋白β 1-42 可预测帕金森病的认知下降。
Neurology. 2010 Sep 21;75(12):1055-61. doi: 10.1212/WNL.0b013e3181f39a78. Epub 2010 Aug 18.
8
A 12-year population-based study of psychosis in Parkinson disease.一项基于人群的帕金森病精神病12年研究。
Arch Neurol. 2010 Aug;67(8):996-1001. doi: 10.1001/archneurol.2010.166.
9
Pathological gambling in Parkinson disease is reduced by amantadine.帕金森病患者的病理性赌博行为可通过金刚烷胺减少。
Ann Neurol. 2010 Sep;68(3):400-4. doi: 10.1002/ana.22029.
10
Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease.盐酸托莫西汀治疗帕金森病伴发抑郁及其他神经精神症状
Neurology. 2010 Aug 3;75(5):448-55. doi: 10.1212/WNL.0b013e3181ebdd79.